Inhibrx Biosciences, Inc. Common Stock (NASDAQ: INBX) last traded at $103.63, up 4.52% on the session. The quote above updates while this page is open; the figures below are drawn from Inhibrx Biosciences, Inc. Common Stock’s own filings and are restated only when a new one is published.
Inhibrx Biosciences, Inc. Common Stock trades on NASDAQ under the ticker INBX. Its market capitalisation is $1.53 billion.
Valuation measures for Inhibrx Biosciences, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.53B |
|---|---|
| Enterprise value | $1.60B |
| Price / sales | 1173.22 |
| Beta | 2.52 |
Trailing-twelve-month figures tagged in Inhibrx Biosciences, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $1.30M |
|---|---|
| Net income (TTM) | -$138.18M |
| EPS (TTM) | -$8.88 |
| Operating margin | -9831.62% |
| Cash | $133.34M |
Range and volume for INBX over the past 52 weeks.
| 52-week high | $155.29 |
|---|---|
| 52-week low | $24.27 |
| Volume | 220.2K |
| Average volume | 298.7K |
| Previous close | $99.15 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.